bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Sepsis is the body’s life-threatening, imbalanced response to a severe infection. The condition affects 1.7 million people and takes 270,000 lives in the U.S. every year. This year, we face additional risks because of the threat of COVID-19.
As major progress was made in reducing the impact of other diseases, hepatitis became what the World Health Organization (WHO) refers to as a long-neglected epidemic, causing devastating and complex health problems. No longer overshadowed, hepatitis has moved into the spotlight as one of the world’s leading causes of death.
As cases of COVID-19 are on the rise again in several places in the U.S., the need for effective treatment remains. Many potential COVID-19 treatments that could have an impact on our ability to fight the virus are currently being developed or tested in clinical trials.
In the United States, Group B Streptococcus (GBS) bacteria are a leading cause of meningitis and sepsis in a newborn’s first three months of life. The bacteria may be passed from pregnant women to their babies during delivery, because about one in every four pregnant women carry GBS bacteria in their body.
A 2018 paper jointly published by three leading infectious disease...
Amid the spread of COVID-19, testing for SARS-COV-2, the virus...